Could Fingolimod Combined with Bevacizumab Be a New Hope in Glioblastoma Treatment?

Glioblastoma, classified as a grade IV astrocytoma, is an aggressive and malignant primary brain tumor with no known cure. Despite the implementation of standard medical and surgical treatment protocols, the disease often progresses with unsatisfactory outcomes. This study aimed to evaluate the cyto...

Full description

Bibliographic Details

Published in:	Current Issues in Molecular Biology
Main Authors:	Murat Baloglu, Canan Vejselova Sezer, Hüseyin Izgördü, Ibrahim Yilmaz, Hatice Mehtap Kutlu
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Subjects:	apoptosis bevacizumab fingolimod glioblastoma
Online Access:	https://www.mdpi.com/1467-3045/47/6/394